Therefore, the lysosomal enzyme (cathepsin G and cathepsin D), CFH metabolites (LVV-H7), and angiotensin II may act as different indicators to guide clinical infection outcomes, including sepsis, shock, or septic shock. This evidence concerns the gene CTSD and infection.